Chardan Capital initiates coverage on StemCells (NASDAQ: STEM) with a Buy rating and $1.45 price target.
This article: 80 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE